Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
metis - but they are not short selling, they are just selling and matching the other side on the conversion. If the 'selling' pushes down the price, well all the better. You might say that's market abuse, but I'm sure they don't care, as they are Dubai based
Sorry metris20, my mind was wondering - must be the shear stresses on AVO's SP. Anyway, with regards to your opinion on the short selling, I think what was said by the company is misleading, as Bracknor is never short. It could just exercise some of the 300,000 odd warrants its just been issued with to close the position off. Or it could just forward sell knowing it has the stock to close or is going to get the stock to close, which I suspect happened on 2nd March - bargain dated 1st March for 193,506 shares at 45.9p. If one has the stock or can get hold of stock, then that's technically not going short. Best of luck
Looks like a little bit of buying ahead of the presentation, but I sense, I plus others are wary of buying too much into whatever comes out of this. There could be a up flip in the share price, but the shear weight of Bracknor unloading shares can only have one outcome, new lows
Will be interesting what is said in the presentations Mon & Tue next wk. I assume it won't be demonstrating a working machine, as this would be material news and would be need to released beforehand. The future of this project is all about funding, without it, it will never happen. Obviously. Bracknor isn't the first door to go knocking on, so I can only assume no other finance was available. Which leads me to Bracknor. Either it hasn't done its maths properly or has miss-understood past trading volumes, both unlikely. So how is it ever going to sell enough shares to cover itself from the risk of AVO going pop. It doesn't make sense and unless AVO can create enough news flow for Bracknor to sell into in an orderly manner, it will have to pump stock on a negative story. I notice each tranche has to be converted into shares within 12 mths. At this rate it will take 12 mths for Bracknor to convert tranche 1, but subject to an EGM ok has another 9 tranches to go, by which time, unless it can dump a lot of shares in going to reach its 29% limit. Perhaps it has been told the news flow is going to be good (or make it up as the CEO of Cloudtag did) to create volume. If this doesn't happen, there can only be one outcome (unless it gets other funding) total obliteration of it mkt cap
Well I definitely never held CTAG or some of the other speculative ramped to death rubbish. If possible short those. I just see so many of these hyped stocks and it usually always ends in tears. I'm not saying SYM is rubbish, but on a trading basis look at the 14 day RSI, look at the fundamentals of the business. Normal companies, don't just double in a month and I don't think SYM , with its track record and competitors, yet falls into the super growth league. Maybe one day.
Was invested. I do like what they are doing, but investors should realise there are a lot of companies in this game, the biggest being Wells Plastics in the UK, Willow Ridge Plastics in the US, Environmental Products Inc (EPI) in Canada (biggest) Schulman German - the whole world market for PE & PP additives for bags is only around £45m! There are more doing it in slightly different ways. The science has been around for 30 yrs, so obviously quite a few in the game. I have no idea if a fund raise is around the corner, but I hate these sudden spikes, which are usually caused by company promotion, tipsters and release of news flow. From personal experience it is share promotion for a reason and out pops a fund raise. At 9p i was happy to take my money off the table, as their cash position is too tight for me, but I wish you the best of luck. Where does the £1m PBT come from?
The £23k comes from the cash flow statement at half year 30 June 2016- cash & cash equivalents - which includes £22k bank overdraft, so actual £1k. Forecasts from brokers, last updated Oct 2016. It also debt of £388k and when using the £45k on the balance ( cash flow more accurate) it has net debt of £343k. It did placings in 2014 and 2015 and if I were management I would use the current share price movement to do so again - one can never have too much cash! So cash is very tight and it looks quite expensive at 10p after its recent spike IMHO. How do you come to the current valuation? Always happy to hear both sides.
Mrbond - my worry is it will need to raise cash soon, because at the half year it was still burning cash (£280k) and only had £23,000 left and unless there has been a big turn around in H2, the auditors will uncomfortable signing off. I know it does invoice discounting, but the cash burn was after that. I see the broker has a forecast of £200k PBT for 2017, so at a market cap of £15m looks way ahead of the game IMHO
938 thanks for the detail explanation! I got involved with AVO on the back of a placing April 2014 and the whole LIGHT project was sold as being way more advanced than it really was. I know one expects management to be bullish, but there are magnitudes and from what I see today, it is not much more developed than it was in then. The only difference is it has burnt through a lot of cash. To get LIGHT to a commercially viable product, approved and tested will cost at least £50m IMHO and I'm with its track record it is unlikely to get this. I wish investors the best of luck
938 forget the physics side, an area we all hope LIGHT will excel. The software side I'm talking about control part done by the operator, for mapping, calculating bone density, accuracy of delivery etc. The part that makes all the physics work to meet its target. I don't think people understand it has take years for its competitors to develop safe reliable software. There was an interesting bit of research done by UCLH (may 2013) about how future proof it PBT investment would be and obviously analysed the risks from the likes of AVO. It concluded they were 5-10 away for clinical availability and even longer for commercial availability.
schlepper - what they say about prohibited from short selling is misleading, as technically Bracknor isn't going short as it will always have the stock to cover on the conversion. I remember VAST resources stated the same thing when it took out one of these deals with Bracknor back in Oct 2016 gave certain assurances etc. The share price cratered. Bracknor is still exercising warrants (21 Feb 2017). Whatever way AVO try and spin its a death spiral finance deal, otherwise Bracknor would just have given them a conventional convertible loan, with a coupon attached. Bracknor are not in that game. At some stage the share price has to collapse IMHO. Sad, but just too many broken promises
938Mev. The hardware is just like your computer and LIGHT (if they get it working) will be a really good bit of hardware, but controlling the beam and to get it to hit the right spot without damaging good tissue, it needs software. Without it the whole thing is useless. I suggest you raise this issue at it forthcoming presentations, as it is crucial to the whole project, but I suspect you won't make many friends if you do.
meldrew on the kids side UCLH can do that. On the international clientele argument, why not build it and showcase it in a major oversea city, say in Europe, where it has no direct (literally round the corner) competition. Even better, why not China.
I understand its smaller and cheaper (subject to getting it working), but on the precision side, software for conventional PBT units has moved on since AVO embarked on its LIGHT system. I can see no benefit now.
As someone pointed out, on another BB why are they thinking of building a proton beam therapy unit at Harley Street when not more than 20 minutes away on Tottenham Court Road, UCLH a NHS hospital is currently building one and is due to open in 2020. After looking into UCLH it has private rooms and it would be logical for patients use its beam therapy unit. Why is AVO wasting cash it doesn't have on Harley St? Something is not right here.